On Friday, Shares of Exxon Mobil Corporation (NYSE:XOM), climbed 0.93% to $83.14.
ExxonMobil, signed a memorandum of understanding with the Korea Institute of Energy Technology Evaluation and Planning and the Korea Gas Corporation (KOGAS) to hold talk aboutions concerning natural gas technologies and new energy technologies.
The agreement will focus on the natural gas value chain, counting cryogenic materials, hydrogen production and fuel cell utilization, energy efficiency technologies and technologies associated with robotics and automation.
Exxon Mobil Corporation explores for and produces crude oil and natural gas in the United States, Canada/South America, Europe, Africa, Asia, and Australia/Oceania. It also manufactures and markets commodity petrochemicals, counting olefins, aromatics, polyethylene and polypropylene plastics, and specialty products; and transports and sells crude oil, natural gas, and petroleum products.
Shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), dipped 1.09% to $ 0.2720.
AEterna Zentaris Inc., declared it has reached its aim of recruiting 500 patients for its pivotal Phase 3 ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) clinical study with zoptarelin doxorubicin in women with advanced, recurrent or metastatic endometrial cancer. The trial is being conducted in over 120 sites in North America, Europe and Israel. The primary efficacy endpoint is improvement in overall survival.
Following its first pre‑specified interim analysis last April, a Data and Safety Monitoring Board recommended that the ZoptEC Phase 3 study continue as planned. A second interim analysis is predictable during Q4, 2015 at about 192 events, with the final analysis planned at an anticipated 384 events. The trial is predictable to be accomplished by the end of 2016.
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women’s health. The companys product pipeline comprises MACRILEN, which accomplished the Phase 2 trial for use in the diagnosis of adult growth hormone deficiency; and zoptarelin doxorubicin, which is in Phase 3 clinical study zoptarelin doxorubicin in endometrial cancer (ZoptEC) of the compound in women with advanced, recurrent, or metastatic endometrial cancer.
Finally, Kellogg Company (NYSE:K), gained 0.21% $ 63.14.
This summer, as the official breakfast of Little League, Kellogg’s Frosted Flakes is calling all dads and kids to “Show Their Stripes” – spotlighting the way they play sports with a sense of passion, sportsmanship and team spirit. From sharing a moment during a pre-game ritual or encouraging good sportsmanship on the field, the #ShowYourStripes program will celebrate the play in playing sports, and those that show what being a good sport is all about this Little League season.
To kick off the summer, recently Kellogg’s Frosted Flakes released an inspirational video compilation of last year’s best “Show Your Stripes” moments from the 2014 Little League Baseball and Softball World Series, encouraging Dad to hit the field with his kid and make memories of their own during the 2015 season. Head to the Kellogg’s Frosted Flakes YouTube page to check out their “Kids of Summer” video. And throughout this summer, Kellogg’s Frosted Flakes is encouraging everyone to share their #ShowYourStripes moments on social media.
Kellogg Company, together with its auxiliaries, manufactures and markets ready-to-eat cereal and convenience foods. The company operates through U.S. Morning Foods, U.S. Snacks, U.S. Specialty, North America Other, Europe, Latin America, and Asia Pacific segments.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
